Does Inflammation Fuel the Fire in CKD?

American Journal of Kidney Diseases

Volumn 53, Issue 4, 2009, Pages 572-575

  Rifkin, Dena E ^a   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; HOMOCYSTEINE; TUMOR NECROSIS FACTOR RECEPTOR;

AGING; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; EDITORIAL; GLOMERULOSCLEROSIS; HEMOSTASIS; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LEUKOCYTOSIS; METABOLIC SYNDROME X; MICROALBUMINURIA; MORTALITY; MUSCLE WEAKNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SMOKING;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; DISEASE PROGRESSION; FACTOR VII; FACTOR VIII; FIBRINOGEN; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; KIDNEY DISEASES; LEUKOCYTES; RISK FACTORS; SERUM ALBUMIN; VON WILLEBRAND FACTOR;

EID: 62749155355     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.01.001     Document Type: Editorial

References (37)

1. Kannel W.B., Dawber T.R., Kagan A., Revotskie N., and Stokes III J. Factors of risk in the development of coronary heart disease-Six year follow-up experience. The Framingham Study. Ann Intern Med 55 (1961) 33-50
2. Stampfer M.J., Ridker P.M., and Dzau V.J. Risk factor criteria. Circulation 109 (2004) IV3-IV5
3. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
4. Manjunath G., Tighiouart H., Coresh J., et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 63 (2003) 1121-1129
5. Goodpaster B.H., Park S.W., Harris T.B., et al. The loss of skeletal muscle strength, mass, and quality in older adults: The Health, Aging and Body Composition Study. J Gerontol Series A Biol Sci Med Sci 61 (2006) 1059-1064
6. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134-2140
7. Fried L.F., Lee J.S., Shlipak M., et al. Chronic kidney disease and functional limitation in older people: Health, Aging and Body Composition Study. J Am Geriatr Soc 54 (2006) 750-756
8. Hunsicker L.G. The consequences and costs of chronic kidney disease before ESRD. J Am Soc Nephrol 15 (2004) 1363-1364
9. Elsayed E.F., Tighiouart H., Griffith J., et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 167 (2007) 1130-1136
10. Bang H., Vupputuri S., Shoham D.A., et al. SCreening for Occult REnal Disease (SCORED): A simple prediction model for chronic kidney disease. Arch Intern Med 167 (2007) 374-381
11. Gooch K., Culleton B.F., Manns B.J., et al. NSAID use and progression of chronic kidney disease. Am J Med 120 280 (2007) e1-e7
12. Bleyer A.J., Shemanski L.R., Burke G.L., Hansen K.J., and Appel R.G. Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int 57 (2000) 2072-2079
13. Haroun M.K., Jaar B.G., Hoffman S.C., Comstock G.W., Klag M.J., and Coresh J. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 (2003) 2934-2941
14. Ridker P.M., Brown N.J., Vaughan D.E., Harrison D.G., and Mehta J.L. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109 (2004) IV6-IV19
15. Pai J.K., Pischon T., Ma J., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351 (2004) 2599-2610
16. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
17. Diamond J.R. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int Suppl 31 (1991) S29-S34
18. Keane W.F., Kasiske B.L., and O'Donnell M.P. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol 8 (1988) 261-271
19. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
20. Remuzzi G., and Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 339 (1998) 1448-1456
21. Shlipak M.G., Katz R., Kestenbaum B., Fried L.F., Siscovick D., and Sarnak M.J. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis (2008) Aug 26 [Epub ahead of print]
22. Knight E.L., Rimm E.B., Pai J.K., et al. Kidney dysfunction, inflammation, and coronary events: A prospective study. J Am Soc Nephrol 15 (2004) 1897-1903
23. Muntner P., Hamm L.L., Kusek J.W., Chen J., Whelton P.K., and He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140 (2004) 9-17
24. Menon V., Greene T., Wang X., et al. C-Reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 68 (2005) 766-772
25. Stuveling E.M., Hillege H.L., Bakker S.J., Gans R.O., De Jong P.E., and De Zeeuw D. C-Reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63 (2003) 654-661
26. Shlipak M.G., Fried L.F., Crump C., et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107 (2003) 87-92
27. Erlinger T.P., Tarver-Carr M.E., Powe N.R., et al. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis 42 (2003) 256-263
28. Fried L., Solomon C., Shlipak M., et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 15 (2004) 3184-3191
29. Tonelli M., Sacks F., Pfeffer M., Jhangri G.S., and Curhan G. Cholesterol and Recurrent Events Trial I. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68 (2005) 237-245
30. Bash L.D., Erlinger T.P., Coresh J., Marsh-Manzi J., Folsom A.R., and Astor B.C. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 53 (2008) 596-605
31. Winkelmayer W.C., Schneeweiss S., Mogun H., Patrick A.R., Avorn J., and Solomon D.H. Identification of individuals with CKD from Medicare claims data: A validation study. Am J Kidney Dis 46 (2005) 225-232
32. Zoccali C. Biomarkers in chronic kidney disease: Utility and issues towards better understanding. Curr Opin Nephrol Hypertens 14 (2005) 532-537
33. Savoia C., and Schiffrin E.L. Inflammation in hypertension. Curr Opin Nephrol Hypertens 15 (2006) 152-158
34. Lloyd-Jones D.M., Liu K., Tian L., and Greenland P. Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145 (2006) 35-42
35. Verhave J.C., Gansevoort R.T., Hillege H.L., Bakker S.J., De Zeeuw D., and de Jong P.E. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl 92 (2004) S18-S21
36. Halbesma N., Kuiken D.S., Brantsma A.H., et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 17 (2006) 2582-2590
37. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58 (2000) 1703-1710